Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: Comparison of vagus nerve and NANC innervation of the colon

British Journal of Pharmacology

Volumn 129, Issue 4, 2000, Pages 782-790

  Rudd, John A ^a   Qian, Yue Ming ^a   Tsui, Kenneth K C ^a   Jones, Robert L ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

BMY 45778; Cicaprost; Colon; Iloprost; NANC innervation; ONO 1301; Prostacyclin; Prostanoid IP receptors; Vagus nerve

Indexed keywords

7,8 DIHYDRO 5 [2 [[ALPHA (3 PYRIDYL)BENZYLIDENE]AMINOOXY]ETHYL] 1 NAPHTHYLOXYACETIC ACID; BMY 42393; CARBACYCLIN; CICAPROST; ILOPROST; ONO AP 324; PARTIAL AGONIST; PROSTACYCLIN DERIVATIVE; PROSTANOID RECEPTOR; TAPROSTENE; UNCLASSIFIED DRUG; [3 [4 (4,5 DIPHENYL 2 OXAZOLYL) 5 OXAZOLYL]PHENOXY]ACETIC ACID;

ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DEPOLARIZATION; DRUG POTENCY; INTESTINE CONTRACTION; INTESTINE INNERVATION; MALE; NERVE STIMULATION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; STEADY STATE; VAGUS NERVE;

EID: 0034116141     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703090     Document Type: Article

References (40)

1. Armstrong, R.A., Lawrence, R.A., Jones, R.L., Wilson, N.H. & Collier, A. (1989). Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Br. J. Pharmacol, 97, 657-668.
2. Bianchetti, A. & Manara, L. (1990). In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon. Br. J. Pharmacol., 100, 831-839.
3. Bley, K.R., Hunter, J.C., Eglen, R.M. & Smith, J.A. (1998). The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol. Sci.. 19, 141-147.
4. 2-sensitive (EP) receptors. Adv. Prost. Thromb. Leukot. Res., 17A, 467-470.
5. Dong, Y.J., Jones, R.L. & Wilson, N.H. (1986). Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br. J Pharmacol., 87, 97-107.
6. Ek, M., Kurosawa, M., Lundeberg, T. & Ericsson, A. (1998). Activation of vagal afferents after injection of interleukin-1β: role of endogenous prostaglandins. J. Neurosci., 18, 9471-9479.
7. Flohe, H., Bohlke, H., Frankus, E., Kim, S.M.A., Lintz, W., Loschen, G., Michel, G., Muller, B., Schneider, J., Seipp, U., Vollenberg, W. & Wilsmann, K. (1983). Designing prostacyclin analogues. Drug Res., 33, 1240-1248.
8. Foye, W.O. (1990). In: Principles of Medicinal Chemistry. Lea & Febiger: London.
9. Huizinga, J.D. & Thuneberg, L. (1997). Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal disorders. Trends Pharmacol. Sci., 18, 393-403.
10. Ireland, S.J. & Tyers, M.B. (1987). Pharmacological characterisation of 5-hydroxytryptamine-induced depolarisation of the rat isolated vagus nerve. Br. J. Pharmacol., 90, 229-238.
11. 3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324. Br. J. Pharmacol, 125, 1288-1296.
12. Jones, R.L., Qian, Y.M., Wise, H., Wong, H.N.C., Lam, W.L., Chan, H.O., Yim, A.P.C. & Ho, J.K.S. (1997). Relaxant actions of non-prostanoid prostacyclin mimetics on human pulmonary artery. J. Cardiovase. Pharmacol., 29, 525-535.
13. Jones, R.L., Wilson, N.H., Marr, C.G., Muir, G & Armstrong, R.A. (1993). Diphenylmethylazine prostanoids with prostacyclinlike actions on human platelets. J. Lipid. Mediators, 6, 405-410.
14. Kenakin, T.P. (1984). The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to classification of drug receptors. Br. J. Pharmacol., 81, 131-141.
15. Kenakin, T.P. (1985). The quantification of relative efficacy of agonists. J. Pharmacol. Meth., 13, 281-308.
16. Kenakin, T.P. (1999). Efficacy in drug receptor theory: outdated concept or under-valued tool? Trends Pharmacol. Sci., 20, 400-405.
17. 3 receptors. Med. Res. Rev., 10, 441-475.
18. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y. & Narumiya, S. (I997). Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol., 122, 17-24.
19. Kondo, K. & Hamanaka, N. (1995). Prostacyclin mimetics with non-prostanoid structures. Folia Pharmacol. Jpn., 106, 181-191.
20. 2 mimetic with inhibitory activity against thromboxane synthase. Adv. Prost. Thromb. Leuko. Res., 23, 401-403.
21. Lawrence, R.A., Jones, R.L. & Wilson, N.H. (1992). Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br. J. Pharmacol., 105, 271-278.
22. 3H]-iloprost. Neuroscience, 65, 493-503.
23. Matthews, J.S. & Jones, R.L. (1993). Potentiation of aggregation and inhibition of adenylatc cyclase in human platelets by prostaglandin E analogues. Br. J. Pharmacol., 108, 363-369.
24. Meanwell, N.A., Romine, J.L. & Seiler, S.M. (1994). Non-prostanoid prostacyclin mimetics. Drugs Future, 19, 361-383.
25. Merritt, J.E., Hallam, T.J., Brown, A.M., Boyfield, L., Cooper, D.G., Hickey, D.M.B., Jaxa-Charmiec, A.A., Kaumann, A.J., Keen, M., Kelly, E., Kozlowski, U., Lynham, J.A., Moores, K.E., Murray, K.J., MacDermot, J. & Rink, T.J. (1991). Octimibate, a potent non-prostanoid inhibitor of platelet aggregation acts via the prostacyclin receptor. Br. J. Pharmacol., 102, 251-259.
26. 4 receptor antagonist in ferrets. Eur. J. Pharmacol., 321, 333-342.
27. Morton, D.R., Bundy, G.L. & Nishizawa, E.E. (1979). Five-membered ring-modified prostacyclin analogues In: Vane J.R and Bergström S. (eds.). Prostacyclin. Raven Press: New York, pp. 31-41.
28. Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshtda, N., Ueno, A., Ohishi, S. & Narumiya, S. (1997). Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature, 388, 678-682.
29. Qian, Y.M. & Jones, R.L. (1995). Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission. Br. J. Pharmacol., 115, 163-171.
30. 4 receptor. Naunyn-Schmied. Arch. Pharmacol., 346, 496-503.
31. Seiler, S., Brassard, C.L., Federici, M.E., Buchanan, J.O., Zavoico, G.B., Fleming, J.S. & Meanwell N.A. (1994). 2-[3-[2-(4,5-Diphenyl-2-oxazolyl] ethyl] phenoxy] acetic acid (BMY 42393): A new, structurally novel prostacyclin partial agonist: 1) Inhibition of platelet aggregation and mechanism of action studies. Thromb. Res., 74, 115-123.
32. Seiler, S., Brassard, C.L., Federici, M.E., Romine, J. & Meanwell, N.A. (1997). [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-ox-azolyl]phcnoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyi cyclase, cAMP levels, protein kinase, and iloprost binding. Prostaglandins, 53, 21-35.
33. Smith, J.A.M., Amagasu, S.M., Eglen, R.M., Hunter, J.C., Bley, K.R. (1998). Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br. J. Pharmacol., 124, 513-523.
34. Suzuki, M., Kato, K., Noyori, R., Watanabe, Y., Takechi, H., Matsumura, K., Langstrom, B. & Watanabe, Y. (1996). (15R)-16-m-Tolyl-17,18,19,20-tetranorisocarbacyclin: a stable ligand with high binding affinity and selectivity for a prostacyclin receptor in the central nervous system. Angew. Chem. Int. Ed. Engl., 35, 334-336.
35. Suzuki, M., Kato, K., Watanabe, Y., Matsumura, K., Watanabe, Y. & Noyori, R. (1999). 15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin: a simple TIC derivative with potent anti-apoptotic activity lor neuronal cells. Chem. Commun., 307-308.
36. Takechi, H., Matsumura, K., Watanabe, Y., Kato, K., Noyori, R., Suzuki, M. & Watanabe, Y. (1996). A novel subtype of the prostacyclin receptor expressed in the central nervous system. J. Biol. Chem., 271, 5901-5906.
37. 2: An investigation by molecular modelling. J. Computer-aided Mol. Des., 5, 135-148.
38. Wise H. & Jones, R.L. (1996). Focus on prostacyclin and its novel mimetics. Trends Pharmacol. Sci., 17, 17-21.
39. Wise, H., Qian, Y.M. & Jones, R.L. (1995). A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors. Eut. J. Pharmacol., 278, 265-269.
40. Woodward, D.R., Fairbairn, C.E. & Lawrence, R.A. (1997). Identification of the FP-receptor as a discrete entity by radioligand binding in biosystems that exhibit different functional rank orders of potency in response to prostanoids. Adr. Exp. Med. Biol., 400A, 223-227.